Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Researchers develop cancer ’nanobomb’

17.10.2005


University of Delaware researchers are opening a new front in the war on cancer, bringing to bear new nanotechnologies for cancer detection and treatment and introducing a unique nanobomb that can literally blow up breast cancer tumors.



Balaji Panchapakesan, assistant professor of electrical and computer engineering at UD, has recently reported on the discoveries in the journals NanoBiotechnology and Oncology Issues.

He is the lead investigator for a team that includes Eric Wickstrom, professor of biochemistry and molecular biology at Thomas Jefferson University in Philadelphia and his student Greg Cesarone, and UD graduate students Shaoxin Lu, Kousik Sivakumar and postdoctoral researcher Kasif Teker.


Panchapakesan said this is basic research in the very early stages of inquiry and that it would take extensive testing and years of clinical trials before the nanobombs could actually be used in medical applications to treat human beings.

“Make no mistake, we are focused on eradicating cancer,” Panchapakesan said, explaining that the nanobombs are the result of work over the past two years with carbon nanotubes, which are atoms of carbon arranged in tubular form.

Originally, he said, the research team was looking at the use of the carbon nanotubes as drug delivery vehicles. Because they are smaller than the size of a single cell, the nanotubes can provide for the highly selective injection of drugs into individual cells.

As they undertook various experiments, however, the team made a startling discovery. “When you put the atoms in different shapes and forms, they take on different properties at the nanoscale,” Panchapakesan said. “We were experimenting with the molecules and considering optical and thermal properties, and found we could trigger microscopic explosions of nanotubes in wide variety of conditions.”

Explosions in air of loosely packed nanotubes have been seen before in an oxygen environment, creating ignition. However, the work reported by Panchapakesan uses the localized thermal energy imbalance to set off explosions that are intrinsic in nature.

Panchapakesan said the nanobombs are just that, tiny bombs on the nanoscale. “They work almost like cluster bombs,” he said. “Once they are exposed to light and the resulting heat, they start exploding one after another.”

The bombs are created by bundling the carbon nanotubes. With a single nanotube, the heat generated by the light is dissipated by surrounding air. In bundles, the heat cannot dissipate as quickly and the result is “an explosion on the nanoscale,” Panchapakesan said.

When the UD researchers saw the explosions, they realized it might be possible to use the microscopic bombs to kill cancer cells. They recreated the explosions in solutions including water, phosphate and salt, which meant the nanobombs could be used in the human body. In fact the explosions were more dramatic in saline solutions, Panchapakesan said.

“The nanobomb is very selective, very localized and minimally invasive,” Panchapakesan said. “It might cause what I would call nanopain, like a pin prick.”

He believes the nanobomb holds great promise as a therapeutic agent for killing cancer cells, with particular emphasis on breast cancer cells, because its shockwave kills the cancerous cells as well as the biological pathways that carry instructions to generate additional cancerous cells and the small veins that nourish the diseased cells. Also, it can be spread over a wide area to create structural damage to the cancer cells that are close by.

The nanobombs are superior to a variety of current treatments because they are powerful, selective, non-invasive, nontoxic and can incorporate current technology, including microsurgery.

An advantage over other carbon nanotube treatments being considered by scientists is that with nanobombs, the carbon nanotubes are destroyed along with the cancer cells. Once the nanobombs are exploded and kill cancer cells, macrophages can effectively clear the cell debris and the exploded nanotube along with it.

Other treatments retain the carbon nanotubes and nanoparticles intact. If the material finds its way to the kidney or accumulates in the blood vessels, the nanoparticles might cause blockage and create problems, Panchapakesan said. Furthermore, the nanobomb route is probably the only way to use nanotubes without any cytotoxicity as the nanotubes are destroyed completely.

Current surgical techniques are not precise and cancerous cells are often left behind. In addition, cancers in some part of the body, such as arteries and veins, are sometimes considered inoperable. Nanobombs can be used to target any remaining cancerous cells and can be used in any part of the body, allowing the creation of nanobomb therapy for a wide variety of cancers.

Panchapakesan said the method is far better than modern chemotherapy, which is non-selective, kills normal cells as well as cancerous cells and leads to a decline in the quality of life for the patient. “This is valuable in patient management, pain management and overall quality of life,” he said.

Furthermore, Panchapakesan said, the nanobomb is a “very simple technique” and as such will likely prove to be “more robust and with the best chance to succeed.”

Panchapakesan added, “We are just getting started in this area. There is plenty of work ahead to successfully translate this into clinical medicine.”

In addition to treatment, he believes nanotechnology can provide new tools for cancer diagnosis through the use of tiny nanosensors.

“In the future, my vision is that people will have at-home kits that can detect cancer. After work they will be able to go to a clinic, be treated with nanobombs and go home,” Panchapakesan said. While these initial experiments are on breast cancer cells, he is also working to extend his method to prostate cancer and pancreatic cancer.

He also foresees nano-bio-robots or nano-surgical tools that can be placed inside the body to remove tumors in areas previously inaccessible using traditional treatment methods.

Panchapakesan said the team’s findings are the result of interdisciplinary research. “Different sciences come together to make this work,” he said, citing cancer biology, physics, electrical and computer engineering and chemistry. “Interdisciplinary research provides for fresh perspectives and brings about new ideas, which is probably the way to go in the future.”

Funding for the research was provided in part by the Department of Defense’s Congressionally Directed Medical Research Program.

Panchapakesan received his bachelor’s degree in materials engineering at Regional Engineering College in India and doctorate in mechanical engineering from the University of Maryland at College Park in 2001 before joining the faculty at UD. His work is in the area of micro- and nano-electromechanical systems (MEMS),
nanotechnology and biomedical research.

Balaji Panchapakesan | EurekAlert!
Further information:
http://www.ece.udel.edu

More articles from Life Sciences:

nachricht Cancer diagnosis: no more needles?
25.05.2018 | Christian-Albrechts-Universität zu Kiel

nachricht Less is more? Gene switch for healthy aging found
25.05.2018 | Leibniz-Institut für Alternsforschung - Fritz-Lipmann-Institut e.V. (FLI)

All articles from Life Sciences >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Powerful IT security for the car of the future – research alliance develops new approaches

The more electronics steer, accelerate and brake cars, the more important it is to protect them against cyber-attacks. That is why 15 partners from industry and academia will work together over the next three years on new approaches to IT security in self-driving cars. The joint project goes by the name Security For Connected, Autonomous Cars (SecForCARs) and has funding of €7.2 million from the German Federal Ministry of Education and Research. Infineon is leading the project.

Vehicles already offer diverse communication interfaces and more and more automated functions, such as distance and lane-keeping assist systems. At the same...

Im Focus: Molecular switch will facilitate the development of pioneering electro-optical devices

A research team led by physicists at the Technical University of Munich (TUM) has developed molecular nanoswitches that can be toggled between two structurally different states using an applied voltage. They can serve as the basis for a pioneering class of devices that could replace silicon-based components with organic molecules.

The development of new electronic technologies drives the incessant reduction of functional component sizes. In the context of an international collaborative...

Im Focus: LZH showcases laser material processing of tomorrow at the LASYS 2018

At the LASYS 2018, from June 5th to 7th, the Laser Zentrum Hannover e.V. (LZH) will be showcasing processes for the laser material processing of tomorrow in hall 4 at stand 4E75. With blown bomb shells the LZH will present first results of a research project on civil security.

At this year's LASYS, the LZH will exhibit light-based processes such as cutting, welding, ablation and structuring as well as additive manufacturing for...

Im Focus: Self-illuminating pixels for a new display generation

There are videos on the internet that can make one marvel at technology. For example, a smartphone is casually bent around the arm or a thin-film display is rolled in all directions and with almost every diameter. From the user's point of view, this looks fantastic. From a professional point of view, however, the question arises: Is that already possible?

At Display Week 2018, scientists from the Fraunhofer Institute for Applied Polymer Research IAP will be demonstrating today’s technological possibilities and...

Im Focus: Explanation for puzzling quantum oscillations has been found

So-called quantum many-body scars allow quantum systems to stay out of equilibrium much longer, explaining experiment | Study published in Nature Physics

Recently, researchers from Harvard and MIT succeeded in trapping a record 53 atoms and individually controlling their quantum state, realizing what is called a...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

VideoLinks
Industry & Economy
Event News

In focus: Climate adapted plants

25.05.2018 | Event News

Save the date: Forum European Neuroscience – 07-11 July 2018 in Berlin, Germany

02.05.2018 | Event News

Invitation to the upcoming "Current Topics in Bioinformatics: Big Data in Genomics and Medicine"

13.04.2018 | Event News

 
Latest News

In focus: Climate adapted plants

25.05.2018 | Event News

Flow probes from the 3D printer

25.05.2018 | Machine Engineering

Less is more? Gene switch for healthy aging found

25.05.2018 | Life Sciences

VideoLinks
Science & Research
Overview of more VideoLinks >>>